Skip to main content

Table 1 Baseline characteristics of the study cohort

From: High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus

VariableAllSubjects with major adverse cardiovascular eventsSubjects without major adverse cardiovascular eventsP value
N22754021873 
Age ≥ 65 years1400 (62)313 (78)1087 (58)< 0.001
Male1664 (73)270 (67)1394 (74)0.003
Current smoker289 (13)49 (12)240 (13)0.73
T2DM1617 (71)328 (82)1289 (69)< 0.001
Hypertension1997 (88)380 (95)1617 (86)< 0.001
BMI, kg/m225.8 ± 3.625.4 ± 3.925.8 ± 3.60.054
Systolic blood pressure, mmHg137 ± 20140 ± 23137 ± 20< 0.001
Diastolic blood pressure, mmHg73 ± 1170 ± 1274 ± 11< 0.001
Triglycerides, mmol/L1.49 ± 1.021.51 ± 1.111.49 ± 1.000.65
Total cholesterol, mmol/L3.89 ± 0.893.94 ± 1.013.88 ± 0.870.17
HDL-cholesterol, mmol/L1.18 ± 0.331.18 ± 0.331.18 ± 0.330.79
LDL-cholesterol, mmol/L2.01 ± 0.732.06 ± 0.832.01 ± 0.710.22
HbA1c, %7.07 ± 1.397.41 ± 1.517.00 ± 1.36< 0.001
Ln-hs-Tnl, pg/mL2.1 ± 1.22.5 ± 1.42.1 ± 1.1< 0.001
Above cutoff (> 14.2 pg/mL)511 (22)148 (37)363 (19)< 0.001
Ln-BNP, pg/mL3.8 ± 1.14.1 ± 1.33.7 ± 1.1< 0.001
Above cutoff (> 56.7 pg/mL)877 (39)212 (53)665 (36)< 0.001
Ln-Enrollment period, month3.1 ± 1.03.5 ± 0.93.0 ± 1.0< 0.001
  1. Values are mean ± SD or n (%)
  2. BMI body mass index, BNP B-type natriuretic peptide, HbA1c hemoglobin A1c, HDL-C high density lipoprotein cholesterol, hs-Tnl high-sensitivity troponin I, Ln natural logarithm, LDL-C low density lipoprotein cholesterol, T2DM type 2 diabetes mellitus